Circulating Angiopoietin-2, Its Soluble Receptor Tie-2, and Mortality in the General Population
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Aims: To assess the association of circulating concentrations of angiopoietin-2 (Ang-2) and its soluble receptor Tie-2 (sTie-2) with all-cause, cardiovascular, and cancer mortality in a population-based sample. Methods and results: Angiopoietin-2 and sTie-2 were measured in 3220 participants (1665 women; mean age 54.4 years) in the Study of Health in Pomerania (SHIP). Multivariable adjusted hazard ratios (HRs) for mortality were estimated using Cox proportional hazard models. During a median follow-up of 6.2 years, 217 participants died. Ang-2 levels were positively associated with all-cause mortality [HR 1.29; 95% confidence interval (CI) 1.19–1.39 per 1 SD increment; P < 0.001] and cardiovascular mortality (HR 1.32; 95% CI 1.18–1.49; P < 0.001), but not with cancer mortality (HR 1.08; 95% CI 0.89–1.32; P = 0.416). Levels of sTie-2 were not significantly related to all-cause mortality (HR 1.12; 95% CI 0.98–1.27; P = 0.102). Adding Ang-2 to a prediction model for all-cause mortality with standard risk factors slightly improved discrimination (Δ Harrell’s C, 0.008; P < 0.001) but not risk reclassification (continuous net reclassification improvement, −0.015; P = 0.571). Conclusion: In our community-based sample, higher serum Ang-2 concentrations were associated with greater risk for all-cause and cardiovascular mortality, suggesting that subtle increases in Ang-2 levels might reflect processes such as vascular remodelling that are associated with higher mortality risk. Adding Ang-2 to a mortality prediction model only modestly improved discrimination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Fiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933 · cited 1×
“vascular endothelial growth factor A, fibroblast growth factor 2, and tumour necrosis factor-a.(12,47) Overall, these experimental data suggest that Ang-2 is part of a complex network of endothelial growth factors and cytokines that influence structural and functional vascular remodelling.”
BackgroundYeboah, J., Folsom, A. R., Burke, G. L., Johnson, C., Polak, J. F., Post, W., Lima, J. A., Crouse, J. R., & Herrington, D. M. (2009) · Circulation · doi:10.1161/circulationaha.109.864801 · Cited by 888
Angiopoietins: a link between angiogenesis and inflammation
Fiedler, U., & Augustin, H. G. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.004 · Cited by 606
Shimbo, D., Grahame-Clarke, C., Miyake, Y., Rodriguez, C., Sciacca, R., Di Tullio, M., Boden-Albala, B., Sacco, R., & Homma, S. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.05.005 · Cited by 219 · cited 1×
“cursors of incident cardiovascular disease, including heart failure, and mortality.(2,3) Clinical, observational, and experimental studies support”
BackgroundAngiopoietin‐2 expression in breast cancer correlates with lymph node invasion and short survival
Sfiligoi, C., de Luca, A., Cascone, I., Sorbello, V., Fuso, L., Ponzone, R., Biglia, N., Audero, E., Arisio, R., Bussolino, F., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.10851 · Cited by 203 · cited 2×
“Experimental data suggest that Ang-2 modulates breast cancer progression,(20) and Ang-2 mRNA expression in biopsies from patients with breast cancer is correlated with the clinical stage.(21) Similarly, Ang-2 expression in tumour biopsies correlates with the clinical outcome in patients with prostate cancer.”
BackgroundAngiopoietin-2 Stimulates Breast Cancer Metastasis through the α5β1 Integrin-Mediated Pathway
Imanishi, Y., Hu, B., Jarzynka, M. J., Guo, P., Elishaev, E., Bar-Joseph, I., & Cheng, S.-Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4100 · Cited by 190
Volkova, E., Willis, J. A., Wells, J. E., Robinson, B. A., Dachs, G. U., & Currie, M. J. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606005 · Cited by 78
Cited by
Therapeutic targeting of the angiopoietin–TIE pathway
Saharinen, P., Eklund, L., & Alitalo, K. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.278 · Cited by 620
Angiopoietin-2 exacerbates cardiac hypoxia and inflammation after myocardial infarction
Lee, S.-J., Lee, C.-K., Kang, S., Park, I., Kim, Y. H., Kim, S. K., Hong, S. P., Bae, H., He, Y., Kubota, Y., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99659 · Cited by 164
Identifying Novel Biomarkers for Cardiovascular Events or Death in People With Dysglycemia
Gerstein, H. C., Paré, G., McQueen, M. J., Haenel, H., Lee, S. F., Pogue, J., Maggioni, A. P., Yusuf, S., & Hess, S. (2015) · Circulation · doi:10.1161/circulationaha.115.015744 · Cited by 69
Metadata
- Authors
- Lorbeer, R., Baumeister, S. E., Dörr, M., Nauck, M., Grotevendt, A., Völzke, H., Vasan, R. S., Wallaschofski, H., & Lieb, W.
- Venue
- European Journal of Heart Failure
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-12-01
- Volume
- 15
- Issue
- 12
- Pages
- 1327-1334
- ISSN
- 1388-9842 (ISSN-L)
- 1879-0844
- OpenAlex
- W2055486107
- Cited by
- 62
- References
- 8
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Circulating Angiopoietin-2, Its Soluble Receptor Tie-2, and Mortality in the General Population. https://app.cochat.ai/papers/10.1093/eurjhf/hft117
- The paper
- Lorbeer, R., Baumeister, S. E., Dörr, M., Nauck, M., Grotevendt, A., Völzke, H., Vasan, R. S., Wallaschofski, H., & Lieb, W. (2013). Circulating Angiopoietin-2, Its Soluble Receptor Tie-2, and Mortality in the General Population. European Journal of Heart Failure. https://doi.org/10.1093/eurjhf/hft117
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.